Assessing chronic pelvic pain syndrome patients: Blood plasma factors and cortisol saliva

References

• Schaeffer AJ. Epidemiology and demographics of prostatitis. Andrologia 2003;35:252–7.
   PubMed Web of Science ®Google Scholar
• Alexander RB. Treatment of chronic prostatitis. Nat Clin Pract Urol 2004;1:2–3.
   PubMedGoogle Scholar
• Hedelin H, Fall M. Controversies in chronic abacterial prostatitis/pelvic pain syndrome. Scand J Urol Nephrol 2008;42:198–204.
   PubMed Web of Science ®Google Scholar
• Clemens JQ, Nadler RB, Schaeffer AJ, Belani J, Albaugh J, Bushman W. Biofeedback, pelvic floor re-education, and bladder training for male chronic pelvic pain syndrome. Urology 2000;56:951–5.
   PubMed Web of Science ®Google Scholar
• Shoskes DA, Nickel JC, Dolinga R, Prots D. Clinical phenotyping of patients with chronic prostatitis/chronic pelvic pain syndrome and correlation with symptom severity. Urology 2009;73:538–42; discussion 42–3.
   PubMed Web of Science ®Google Scholar
• Alexander RB, Ponniah S, Hasday J, Hebel JR. Elevated levels of proinflammatory cytokines in the semen of patients with chronic prostatitis/chronic pelvic pain syndrome. Urology 1998;52:744–9.
   PubMed Web of Science ®Google Scholar
• Aloisi AM, Pari G, Ceccarelli I, Vecchi I, Ietta F, Lodi L, et al. Gender-related effects of chronic non-malignant pain and opioid therapy on plasma levels of macrophage migration inhibitory factor (MIF). Pain 2005;115:142–51.
   PubMed Web of Science ®Google Scholar
• Pontari MA, Ruggieri MR. Mechanisms in prostatitis/chronic pelvic pain syndrome. J Urol 2008;179:S61–7.
   PubMed Web of Science ®Google Scholar
• Hochreiter WW, Nadler RB, Koch AE, Campbell PL, Ludwig M, Weidner W, et al. Evaluation of the cytokines interleukin 8 and epithelial neutrophil activating peptide 78 as indicators of inflammation in prostatic secretions. Urology 2000;56:1025–9.
   PubMed Web of Science ®Google Scholar
• Khadra A, Fletcher P, Luzzi G, Shattock R, Hay P. Interleukin-8 levels in seminal plasma in chronic prostatitis/chronic pelvic pain syndrome and nonspecific urethritis. BJU Int 2006;97:1043–6.
   PubMed Web of Science ®Google Scholar
• Penna G, Mondaini N, Amuchastegui S, Degli Innocenti S, Carini M, Giubilei G, et al. Seminal plasma cytokines and chemokines in prostate inflammation: interleukin 8 as a predictive biomarker in chronic prostatitis/chronic pelvic pain syndrome and benign prostatic hyperplasia. Eur Urol 2007;51:524–33.
   PubMed Web of Science ®Google Scholar
• He L, Wang Y, Long Z, Jiang C. Clinical significance of IL-2, IL-10, and TNF-[alpha] in prostatic secretion of patients with chronic prostatitis. Urology 2010;75:654–7.
   PubMed Web of Science ®Google Scholar
• Duan Z-G, Yang W-M. Analysis of cytokines (IL-2, IL-8, IL-10) in the expressed prostatic secretions of chronic prostatitis. Zhonghua Nan Ke Xue 2005;11:201–3.
   PubMedGoogle Scholar
• Miller LJ, Fischer KA, Goralnick SJ, Litt M, Burleson JA, Albertsen P, et al. Interleukin-10 levels in seminal plasma: implications for chronic prostatitis–chronic pelvic pain syndrome. J Urol 2002;167:753–6.
   PubMed Web of Science ®Google Scholar
• Desireddi NV, Campbell PL, Stern JA, Sobkoviak R, Chuai S, Shahrara S, et al. Monocyte chemoattractant protein-1 and macrophage inflammatory protein-1[alpha] as possible biomarkers for the chronic pelvic pain syndrome. J Urol 2008;179:1857–62.
   PubMed Web of Science ®Google Scholar
• Aghazarian A, Plas E, Stancik I, Pflüger H, Lackner J. New method for differentiating chronic prostatitis/chronic pelvic pain syndrome IIIA from IIIB involving seminal macrophages and monocytes. Urology 2011;78:918–23.
   PubMed Web of Science ®Google Scholar
• Dimitrakov J, Joffe HV, Soldin SJ, Bolus R, Buffington CAT, Nickel JC. Adrenocortical hormone abnormalities in men with chronic prostatitis/chronic pelvic pain syndrome. Urology 2008;71:261–6.
   PubMed Web of Science ®Google Scholar
• Grieb G, Merk M, Bernhagen J, Bucala R. Macrophage migration inhibitory factor (MIF): a promising biomarker. Drug News Perspect 2010;23:257–64.
   PubMedGoogle Scholar
• Vania Apkarian A, Lavarello S, Randolf A, Berra HH, Chialvo DR, Besedovsky HO, et al. Expression of IL-1[beta] in supraspinal brain regions in rats with neuropathic pain. Neurosci Lett 2006;407:176–81.
   PubMed Web of Science ®Google Scholar
• Korner H, Sedgwick JD. Tumour necrosis factor and lymphotoxin: molecular aspects and role in tissue-specific autoimmunity. Immunol Cell Biol 1996;74:465–72.
   PubMed Web of Science ®Google Scholar
• Anderson RU, Orenberg EK, Morey A, Chavez N, Chan CA. Stress induced hypothalamus–pituitary–adrenal axis responses and disturbances in psychological profiles in men with chronic prostatitis/chronic pelvic pain syndrome. J Urol 2009;182:2319–24.
   PubMed Web of Science ®Google Scholar
• Reiche EMV, Nunes SOV, Morimoto HK. Stress, depression, the immune system, and cancer. Lancet Oncol 2004;5:617–25.
   PubMed Web of Science ®Google Scholar
• Dantzer R, Kelley KW. Stress and immunity: an integrated view of relationships between the brain and the immune system. Life Sci 1989;44:1995–2008.
   PubMed Web of Science ®Google Scholar
• Yao MZ, Gu JF, Wang JH, Sun LY, Lang MF, Liu J, et al. Interleukin-2 gene therapy of chronic neuropathic pain. Neuroscience 2002;112:409–16.
   PubMed Web of Science ®Google Scholar
• Musil R, Schwarz MJ, Riedel M, Dehning S, Cerovecki A, Spellmann I, et al. Elevated macrophage migration inhibitory factor and decreased transforming growth factor-beta levels in major depression – no influence of celecoxib treatment. J Affect Disord 2011;134:217–25.
   PubMed Web of Science ®Google Scholar
• Nickel JC, Downey J, Hunter D, Clark J. Prevalence of prostatitis-like symptoms in a population based study using the National Institutes of Health Chronic Prostatitis Symptom Index. J Urol 2001;165:842–5.
   PubMed Web of Science ®Google Scholar
• Whiteman M, Chu SH, Siau JL, Rose P, Sabapathy K, Schantz JT, et al. The pro-inflammatory oxidant hypochlorous acid induces Bax-dependent mitochondrial permeabilisation and cell death through AIF-/EndoG-dependent pathways. Cell Signal 2007;19:705–14.
   PubMed Web of Science ®Google Scholar
• Malemud CJ. Growth hormone, VEGF and FGF: involvement in rheumatoid arthritis. Clin Chim Acta 2007;375:10–19.
   PubMed Web of Science ®Google Scholar
• Blanco LE, de Serres FJ, Fernandez-Bustillo E, Kassam DA, Arbesu D, Rodriguez C, et al. α1-Antitrypsin and fibromyalgia: new data in favour of the inflammatory hypothesis of fibromyalgia. Med Hypotheses 2005;64:759–69.
   PubMed Web of Science ®Google Scholar
• Thompson ME, Barkhuizen A. Fibromyalgia, hepatitis C infection, and the cytokine connection. Curr Pain Headache Rep 2003;7:342–7.
   PubMedGoogle Scholar
• Kivioja J, Ozenci V, Rinaldi L, Kouwenhoven M, Lindgren U, Link H. Systemic immune response in whiplash injury and ankle sprain: elevated IL-6 and IL-10. Clin Immunol 2001;101:106–12.
   PubMed Web of Science ®Google Scholar
• Rosendal L, Kristiansen J, Gerdle B, Sogaard K, Peolsson M, Kjaer M, et al. Increased levels of interstitial potassium but normal levels of muscle IL-6 and LDH in patients with trapezius myalgia. Pain 2005;119:201–9.
   PubMed Web of Science ®Google Scholar
• Moalem G, Tracey DJ. Immune and inflammatory mechanisms in neuropathic pain. Brain Res Rev 2006;51:240–64.
   PubMed Web of Science ®Google Scholar
• Weidner W, Anderson RU. Evaluation of acute and chronic bacterial prostatitis and diagnostic management of chronic prostatitis/chronic pelvic pain syndrome with special reference to infection/inflammation. Int J Antimicrob Agents 2008;31:91–5.
   PubMed Web of Science ®Google Scholar
• Litwin MS. A review of the development and validation of the National Institutes of Health Chronic Prostatitis Symptom Index. Urology 2002;60:14–18; discussion 8–9.
   PubMed Web of Science ®Google Scholar
• Mitchell RA, Liao H, Chesney J, Fingerle-Rowson G, Baugh J, David J, et al. Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: regulatory role in the innate immune response. Proc Natl Acad Sci USA 2002;99:345–50.
   PubMed Web of Science ®Google Scholar
• Narumiya S, Sugimoto Y, Ushikubi F. Prostanoid receptors: structures, properties, and functions. Physiol Rev 1999;79:1193–226.
   PubMed Web of Science ®Google Scholar